Medtech firms prioritize process automation for clinical trial collaboration.

Wednesday, Aug 13, 2025 6:49 am ET1min read

Veeva Systems has announced the results of its 2025 Veeva MedTech Clinical Benchmark study, which shows that clinical teams in the medical technology sector prioritize reducing manual processes (68%), improving study quality (56%), and gaining better visibility and control (55%) to streamline workflows, work more efficiently with sites, and speed up trials. The study highlights the potential of technology to simplify and standardize clinical trial workflows, improve collaboration, and accelerate research.

Veeva Systems has released the findings of its 2025 Veeva MedTech Clinical Benchmark, highlighting key priorities for clinical teams in the medical technology sector. The study, which surveyed over 100 clinical professionals, reveals that reducing manual processes (68%), improving study quality (56%), and enhancing visibility and control (55%) are top priorities to streamline workflows, improve collaboration, and accelerate research [1].

The report underscores the significant challenges faced by medtech companies, including on-time data entry and data quality, document and data exchange, and monitoring and compliance. However, only 14% of medtechs with revenue over $1 billion and 24% with revenue under $1 billion have site collaboration tools in place, indicating a gap in the industry's efforts to improve trial efficiency and expedite study timelines [1].

Manual processes and regulatory compliance are cited as major hurdles, increasing operational costs and causing delays. To mitigate these risks, 58% of medtechs plan to prioritize data collection and cleaning in the next year. Additionally, nearly three-quarters (72%) of medtech organizations are planning to invest in AI and ML infrastructure to standardize data and make it AI-ready [1].

The study also highlights the importance of technology in simplifying and standardizing clinical workflows, enabling more effective collaboration with research sites, and speeding up trials. This shift towards technological solutions is driven by the need to balance economic pressures and new regulations, ensuring data integrity, operational efficiency, and connected processes across stakeholders [1].

References:
[1] https://www.prnewswire.com/news-releases/research-shows-medtechs-prioritizing-site-collaboration-and-data-quality-302527421.html

Comments



Add a public comment...
No comments

No comments yet